A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
Kyuson Yun, Ph.D.
Associate Professor
Department of Neurology
Houston Methodist Chair, Neurodegenerative Disease Research
Houston Methodist Research Institute
Weill Cornell Medical College
Pioneers in Biomedical Research Seminar
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
Date: May 2, 2025
Time: 11 a.m. - 12 p.m.
About this Seminar
While immunotherapies have shown remarkable efficacy in some cancers, most solid tumors, including brain cancers, are resistant to immunotherapies. Immunotherapies are ideal for treating brain cancers since immune cells can cross the blood brain barrier (BBB) and track and selectively kill infiltrating brain cancer cells while sparing normal brain cells. Unfortunately, most brain cancer trials with immunotherapies have failed to demonstrate significant benefits to brain cancer patients thus far. Dr. Yun and her team recently identified S100A4 as a critical regulator of immune suppressive myeloid and T cells in GBM through single cell sequencing analysis, and developed a novel S100A4 blocking antibody. To enhance BBB penetration, we also developed a bispecific antibody that crosses the BBB and reprograms the GBM TME to more an inflammatory state. Dr. Yun will discuss our progress in understanding the immune suppressive microenvironment in GBM and the therapeutic potential of a novel bispecific antibody for treating brain cancers.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Center — Roanoke. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Pandemics — The Lessons I've Learned , homeNov. 6, 2025, 5:30 p.m. (Reception at 5 p.m.) | Teresa Lambe, Ph.D., OBE, Calleva Head of Vaccine Immunology, Professor of Vaccinology and Immunology, University of Oxford | Maury Strauss Distinguished Public Lecture
-
Home Item
Understanding Vascular Morphogenesis and Morphology: Live Insights from Zebrafish , homeNov. 21, 2025, 11:00 a.m. | Arndt F. Siekmann, Ph.D., Associate Professor, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute
-
Home Item
The Metabolic Switch in Development and Degeneration , homeDec. 12, 2025, 11:00 a.m. | Elizabeth Jonas, M.D., Harvey and Kate Cushing Professor of Internal Medicine (Endocrinology), Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
Innovative Strategies for Overcoming Challenges in Brain Tumor Treatment , homeJan. 16, 2026, 11:00 a.m. | Kristin Huntoon, Ph.D., D.O., Assistant Professor, Department of Neurosurgery, University of Arizona | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Maury Strauss Distinguished Public Lecture , homeJan. 22, 2026, 5:30 p.m. (Reception at 5 p.m.) | Holly Ingraham, Ph.D., Professor, Cellular and Molecular Pharmacology; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
Policies to Reduce Ultra-processed Foods: Lessons From Around the Globe , homeJan. 30, 2026, 11:00 a.m. | Lindsey Smith Taillie, Ph.D., MPH, Associate Professor of Nutrition, Associate Chair of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center